Academic detailing is an evidence-based approach to informing clinicians about therapeutic options for various illnesses and best practices for managing chronic conditions. It is a real-world application of the Division of Pharmacoepidemiology’s research into comparative effectiveness, adherence, cost-effectiveness, and several other fields. The National Resource Center for Academic Detailing (NaRCAD), directed by Michael Fischer, MD, MS, offers two sessions a year on how to be an academic detailer, in addition to needs assessments, program evaluations, and assistance in developing academic detailing materials.
A major focus of research in the division is on improving pharmacoepidemiologic methods and the validity of pharmacoepidemiologic research. The HD-Pharmacoepi site is home to many resources developed by faculty and are available for free download and use, including the high-dimensional propensity score developed by Sebastian Schneeweiss and Jeremy Rassen.
Alosa is a nonprofit organization dedicated to the dissemination of accurate, unbiased, and non-commercial information about medications for healthcare professionals and patients. Educational services such as interactive outreach to physicians, classes, presentations, seminars and conferences are offered on the development, regulation, risks, and benefits of prescription drugs.
IDIS manages Academic Detailing programs in Massachusetts, Pennsylvania, and Washington, DC. Clinical materials are developed by DoPE faculty and are freely available for non-commercial use.
The DEcIDE Methods Center (DMC) at Brigham and Women’s Hospital is funded by the Agency for Healthcare Research and Quality (AHRQ) to develop and improve methods for conducting comparative effectiveness research (CER). The DMC complements and supports new research conducted under the DEcIDE Network and other funding mechanisms via peer-review and learning network activities. Educational activites include monthly methods webinars and scans of the CER methods literature, which can be found here. Key personnel include Sebastian Schneeweiss (Director), John Seeger (Senior Pharmacoepidemiologist), and Liz Robinson (Project Manager).